Asker Healthcare (ST:ASKER) — Stock Price
Asker Healthcare (ST:ASKER) is currently trading at Skr83.00 SEK, down 2.01% today. Over the past 52 weeks, shares have ranged between Skr59.45 and Skr123.92. This page tracks Asker Healthcare's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Asker Healthcare (ASKER) market capitalisation.
Asker Healthcare (ASKER) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Asker Healthcare's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.
Asker Healthcare Income Statement — Revenue, Profit & Earnings by Year
Asker Healthcare's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Skr16.79 Billion | Skr15.03 Billion | Skr13.45 Billion | Skr11.72 Billion | Skr9.35 Billion |
| Cost of Revenue | Skr10.73 Billion | Skr9.15 Billion | Skr8.93 Billion | Skr7.94 Billion | Skr6.74 Billion |
| Gross Profit | Skr6.05 Billion | Skr5.88 Billion | Skr4.52 Billion | Skr3.78 Billion | Skr2.61 Billion |
| Research & Development | — | — | — | — | — |
| SG&A | Skr1.68 Billion | Skr1.33 Billion | Skr1.14 Billion | Skr760.00 Million | — |
| Total Operating Expenses | Skr4.78 Billion | Skr4.91 Billion | Skr3.94 Billion | Skr3.07 Billion | Skr2.02 Billion |
| Operating Income | Skr1.28 Billion | Skr966.00 Million | Skr579.00 Million | Skr708.00 Million | Skr598.00 Million |
| EBITDA | Skr2.09 Billion | Skr1.47 Billion | Skr1.12 Billion | Skr1.12 Billion | Skr670.00 Million |
| EBIT | Skr1.28 Billion | Skr861.00 Million | Skr572.00 Million | Skr721.00 Million | Skr605.00 Million |
| Interest Expense | Skr572.00 Million | Skr319.00 Million | Skr276.00 Million | Skr179.00 Million | Skr22.00 Million |
| Income Before Tax | Skr659.00 Million | Skr559.00 Million | Skr308.00 Million | Skr561.00 Million | Skr544.00 Million |
| Income Tax Expense | Skr149.00 Million | Skr183.00 Million | Skr103.00 Million | Skr127.00 Million | Skr74.00 Million |
| Net Income | Skr492.00 Million | Skr360.00 Million | Skr203.00 Million | Skr430.00 Million | Skr467.00 Million |
Asker Healthcare Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Asker Healthcare's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Skr16.77 Billion | Skr13.12 Billion | Skr11.33 Billion | Skr10.23 Billion | Skr7.36 Billion |
| Total Current Assets | Skr5.47 Billion | Skr4.48 Billion | Skr4.00 Billion | Skr3.41 Billion | Skr2.95 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Skr2.55 Billion | Skr1.97 Billion | Skr2.00 Billion | Skr1.65 Billion | Skr1.11 Billion |
| Inventory | Skr2.04 Billion | Skr1.82 Billion | Skr1.44 Billion | Skr1.42 Billion | Skr1.12 Billion |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | Skr6.37 Billion | Skr5.10 Billion | Skr4.70 Billion | Skr4.47 Billion | Skr3.36 Billion |
| Total Liabilities | Skr10.19 Billion | Skr9.62 Billion | Skr8.29 Billion | Skr7.44 Billion | Skr5.54 Billion |
| Total Current Liabilities | Skr4.04 Billion | Skr3.20 Billion | Skr2.86 Billion | Skr2.23 Billion | Skr1.68 Billion |
| Long-term Debt | Skr4.22 Billion | Skr4.63 Billion | Skr3.99 Billion | Skr3.99 Billion | — |
| Net Debt | Skr4.93 Billion | Skr5.47 Billion | Skr4.58 Billion | Skr4.53 Billion | Skr3.43 Billion |
| Total Stockholder Equity | Skr6.55 Billion | Skr3.47 Billion | Skr3.02 Billion | Skr2.76 Billion | Skr1.79 Billion |
| Retained Earnings | Skr2.15 Billion | Skr1.65 Billion | Skr1.30 Billion | Skr1.12 Billion | Skr688.00 Million |
Asker Healthcare Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Asker Healthcare generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Skr1.33 Billion | Skr1.23 Billion | Skr1.05 Billion | Skr976.00 Million | Skr382.00 Million |
| Capital Expenditures | Skr590.00 Million | Skr348.00 Million | Skr151.00 Million | Skr123.00 Million | Skr124.00 Million |
| Free Cash Flow | Skr738.00 Million | Skr879.00 Million | Skr901.00 Million | Skr853.00 Million | Skr258.00 Million |
| Investing Cash Flow | Skr-2.91 Billion | Skr-1.46 Billion | Skr-783.00 Million | Skr-1.86 Billion | Skr-843.00 Million |
| Financing Cash Flow | Skr2.02 Billion | Skr305.00 Million | Skr-83.00 Million | Skr572.00 Million | Skr619.00 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Skr816.00 Million | Skr608.00 Million | Skr548.00 Million | Skr395.00 Million | Skr230.00 Million |
| Change in Cash | Skr394.00 Million | Skr99.00 Million | Skr180.00 Million | Skr-283.00 Million | Skr494.00 Million |
Asker Healthcare Earnings History — EPS Actual vs. Analyst Estimates
Track Asker Healthcare's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 06, 2026 | 0.53 | 0.57 | -7.02% |
| Feb 10, 2026 | 0.35 | 0.80 | -55.88% |
| Nov 06, 2025 | 0.37 | 0.49 | -24.49% |
| Jul 22, 2025 | 0.34 | — | — |
| May 13, 2025 | 0.28 | — | — |